PolyPid Announces New Candidate PD01B For Diabetic Foot Infections, First-In-Human Study Expected In 2H 2027; Says D-PLEX100 On Track For November 28 PDUFA Date
Share
Why It Matters
PolyPid is testing a new medicine for diabetic foot infections. Watch if their current medicine gets approved on schedule in November.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.